Exploring the Association Between Air Pollutant Exposure and Krebs von den Lungen-6 (KL 6) Serum Levels in Outdoor and Indoor Workers in Banyumas District, Central Java

Exploring the Association Between Air Pollutant Exposure and Krebs von den Lungen-6 (KL 6) Serum Levels in Outdoor and Indoor Workers in Banyumas District, Central Java

Introduction: Indonesia ranks 8th globally in the air pollution index, with poor air quality causing premature deaths from lung ailments such as interstitial lung diseases. Krebs von den Lungen-6 (KL 6) can be used to detect lung disease caused by air pollution. However, the number of studies invest...

Full description

Bibliographic Details
Main Authors:	Euis Tia Istianah, Nendyah Roestijawati, Joko Mulyanto
Format:	Article
Language:	English
Published:	Universitas Airlangga 2022-07-01
Series:	Jurnal Kesehatan Lingkungan
Subjects:	air pollutant indoor workers krebs von den lungen 6 (kl-6) outdoor workers
Online Access:	https://e-journal.unair.ac.id/JKL/article/view/34267

Similar Items

Serum Krebs von den Lungen (KL-6) level as a marker of exacerbation of interstitial lung diseases
by: Zainab H. Saeed, et al.
Published: (2020-11-01)

Krebs von den Lungen-6 glycoprotein circulating levels are not useful as prognostic marker in COVID-19 pneumonia: A large prospective cohort study
by: Ivan Castellví, et al.
Published: (2022-08-01)

Significance of serum Krebs von den Lungen-6 in systemic sclerosis
by: Noha Hosni Ibrahim, et al.
Published: (2023-11-01)

Circulatory Serum Krebs von Den Lungen-6 and Surfactant Protein-D Concentrations Predict Interstitial Lung Disease Progression and Mortality
by: Meghna Rai, et al.
Published: (2023-04-01)

Prediction Value of KREBS Von Den Lungen-6 (KL-6) Biomarker in COVID-19 Patients: A Systematic Review and Meta-Analysis
by: Michal Matuszewski, et al.
Published: (2022-11-01)

Blood Krebs von den Lungen-6 levels predict treatment response to antifibrotic therapy in patients with idiopathic pulmonary fibrosis
by: Myeong Geun Choi, et al.
Published: (2022-12-01)

Exploring the Role of Krebs von den Lungen-6 in Severe to Critical COVID-19 Patients
by: Vito D’Agnano, et al.
Published: (2022-07-01)

Krebs von den lungen-6 as a clinical marker for hypersensitivity pneumonitis: A meta-analysis and bioinformatics analysis
by: Jie He, et al.
Published: (2022-11-01)

Establishing Sex-Dependent Reference Intervals for KL-6 in Danish Adults
by: Stine Bakkensen Bruun, et al.
Published: (2023-06-01)

Serum concentrations of Krebs von den Lungen-6, surfactant protein D, and matrix metalloproteinase-2 as diagnostic biomarkers in patients with asbestosis and silicosis: a case–control study
by: Changjiang Xue, et al.
Published: (2017-11-01)

Serum Osteopontin, KL-6, and Syndecan-4 as Potential Biomarkers in the Diagnosis of Coal Workers’ Pneumoconiosis: A Case–Control Study
by: Hou Z, et al.
Published: (2023-06-01)

KL-6 as an Immunological Biomarker Predicts the Severity, Progression, Acute Exacerbation, and Poor Outcomes of Interstitial Lung Disease: A Systematic Review and Meta-Analysis
by: Tao Zhang, et al.
Published: (2021-12-01)

The value of serum Krebs von den lungen-6 as a diagnostic marker in connective tissue disease associated with interstitial lung disease
by: Hua Ma, et al.
Published: (2020-01-01)

Role of Krebs von den Lungen-6 (KL-6) in Assessing Hypersensitivity Pneumonitis
by: Amira Ismail Mostafa, et al.
Published: (2021-07-01)

The Role of SARS-CoV-2 Nucleocapsidic Antigen and Krebs von den Lungen 6 Serum Levels in Predicting COVID-19 Pneumonia Outcome
by: Stefano Sanduzzi Zamparelli, et al.
Published: (2024-03-01)

Krebs von den Lungen 6 (KL-6) levels in COVID-19 ICU patients are associated with mortality
by: Giuliana Scarpati, et al.
Published: (2022-08-01)

Role of BAL and Serum Krebs von den Lungen-6 (KL-6) in Patients with Pulmonary Fibrosis
by: Piera Soccio, et al.
Published: (2024-01-01)

Serum Concentrations of KL-6 in Patients with IPF and Lung Cancer and Serial Measurements of KL-6 in IPF Patients Treated with Antifibrotic Therapy
by: Miriana d’Alessandro, et al.
Published: (2021-02-01)

Serum SP-A and KL-6 levels can predict the improvement and deterioration of patients with interstitial pneumonia with autoimmune features
by: Jingxian Wang, et al.
Published: (2020-12-01)

Baseline plasma KL-6 level predicts adverse outcomes in patients with idiopathic pulmonary fibrosis receiving nintedanib: a retrospective real-world cohort study
by: Tang-Hsiu Huang, et al.
Published: (2021-05-01)

Waterproofing Spray-Associated Lung Injury Review: Differences between Cases of Early and Delayed Improvement of Waterproofing Spray-Associated Lung Injury
by: Norio Kodaka, et al.
Published: (2023-03-01)

A case of familial hot tub lung
by: Yoshihiro Kitahara, et al.
Published: (2016-01-01)

Effects of molecular structural variants on serum Krebs von den Lungen-6 levels in sarcoidosis
by: Shigemura Masahiko, et al.
Published: (2012-07-01)

Novel Usefulness of Krebs von den Lungen 6 (KL-6) with Hemoglobin and Lactate Dehydrogenase for Assessing Bone Marrow Fibrosis
by: Minjeong Nam, et al.
Published: (2022-03-01)

Krebs von den Lungen-6 (KL-6) Levels in Post-COVID Follow-Up: Differences According to the Severity of COVID-19
by: Carlos Carpio, et al.
Published: (2023-09-01)

Rapidly progressive organizing pneumonia associated with COVID-19
by: Hiroshi Horii, et al.
Published: (2020-01-01)

Distribution of Presepsin, Krebs von den Lungen 6, and Surfactant Protein A in Umbilical Cord Blood
by: Minjeong Nam, et al.
Published: (2022-09-01)

Surfactant protein A as a biomarker of outcomes of anti-fibrotic drug therapy in patients with idiopathic pulmonary fibrosis
by: Takumi Yoshikawa, et al.
Published: (2020-01-01)

Analysis of Early Biomarkers Associated with the Development of Critical Respiratory Failure in Coronavirus Disease 2019 (COVID-19)
by: Hiroyoshi Yamada, et al.
Published: (2022-01-01)

Establishment and validation of nomogram for predicting immuno checkpoint inhibitor related pneumonia
by: Xiaoqi Li, et al.
Published: (2022-09-01)

Surfactant protein D: a useful marker for differentiation of drug-induced pneumonia and bacterial pneumonia
by: Yuko Waseda, et al.
Published: (2021-06-01)

A proposed prognostic prediction score for pleuroparenchymal fibroelastosis
by: Yoshiaki Kinoshita, et al.
Published: (2021-07-01)

Correlation between serum KL-6 level and severity of SARD-related ILD
by: Emmy Pranggono, et al.
Published: (2022-04-01)

Serum Biomarkers in a Radiological Pattern of Non-Fibrotic Hypersensitivity Pneumonitis: Implications for Mechanistic Difference and Differential Diagnosis
by: Takayuki Takimoto, et al.
Published: (2022-06-01)

Identification of biomarkers by machine learning classifiers to assist diagnose rheumatoid arthritis-associated interstitial lung disease
by: Yan Qin, et al.
Published: (2022-05-01)

Exploring the Role of Biomarkers Associated with Alveolar Damage and Dysfunction in Idiopathic Pulmonary Fibrosis—A Systematic Review
by: Alexandra-Simona Zamfir, et al.
Published: (2023-11-01)

Peritoneal malignant mesothelioma with epithelioid type, demonstrating high serum and ascitic KL-6 levels: immunohistochemical analyses
by: Saifun Nahar, et al.
Published: (2015-09-01)

Peak value of serum KL-6 may be useful for predicting poor prognosis of severe COVID-19 patients
by: Shuhei Maruyama, et al.
Published: (2022-05-01)

Drug-induced interstitial lung disease in the treatment of malignant lymphoma as a potential diagnostic marker: a comparison of serum Krebs von Lungen-6 and thymus and activation-regulated chemokine/CC chemokine ligand 17
by: Yamane H, et al.
Published: (2018-08-01)

KL-6 in adult polymyositis and dermatomyositis patients and its correlation with interstitial lung disease
by: Mayada Khalil, et al.
Published: (2023-12-01)